Automatic detection of drug interaction mismatches in package inserts

The US Code of Federal Regulation (21 CFR 207) mandates that pharmaceutical manufacturers submit their FDA-approved drug information as medication Package Insert (PI). PI should provide comprehensive, current, and accurate information about the medical use of a drug. However, PI narratives are cumbersome for healthcare providers to navigate and are therefore rarely used by them. We are developing Paracelsus, a tool for automatically extracting structured drug information from PI. Paracelsus has the potential to allow healthcare providers to benefit from the rich drug information in PI for patient care. In this study, we report the development and evaluation of Paracelsus on drug-drug interactions. We show that Paracelsus performs with a high accuracy, discovering interactions not covered by other medical compendia, and in addition automatically detecting inconsistencies in the package inserts.

[1]  Hong Yu,et al.  Biomedical negation scope detection with conditional random fields , 2010, J. Am. Medical Informatics Assoc..

[2]  P. Maurette [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[3]  International Conference on Advances in Computing, Communications and Informatics, ICACCI 2013, Mysore, India, August 22-25, 2013 , 2013, ICACCI.

[4]  Robert J Weber,et al.  Contradictions in Contraindications for Drug-Drug Interactions , 2011, The Annals of pharmacotherapy.

[5]  T K Hazlet,et al.  Performance of community pharmacy drug interaction software. , 2001, Journal of the American Pharmaceutical Association.

[6]  Nicholas Christenfeld,et al.  Increase in US medication-error deaths between 1983 and 1993 , 1998, The Lancet.

[7]  Michiko Ohkura,et al.  Analysis on descriptions of precautionary statements in package inserts of medicines , 2012, Drug, healthcare and patient safety.

[8]  J. Hallas,et al.  Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study. , 1998, Danish medical bulletin.

[9]  Jon D Duke,et al.  ADESSA: A Real-Time Decision Support Service for Delivery of Semantically Coded Adverse Drug Event Data. , 2010, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[10]  A. Vitry,et al.  Comparative assessment of four drug interaction compendia. , 2007, British journal of clinical pharmacology.

[11]  R. Altman,et al.  Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.

[12]  P W Ament,et al.  Clinically significant drug interactions. , 2000, American family physician.

[13]  Jon Duke,et al.  A quantitative analysis of adverse events and "overwarning" in drug labeling. , 2011, Archives of internal medicine.

[14]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[15]  N. Christenfeld,et al.  Increase in US medication-error deaths , 1998, The Lancet.

[16]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[17]  Tomasz Z Jodlowski,et al.  How Up-to-Date is Your Drug-Drug Interaction Database? , 2011, The Annals of pharmacotherapy.